RPG Life Sciences Share Price
Small Cap | Pharmaceuticals and health care | NSE: RPGLIFE | BSE: 532983
₹2,419.50 
181.20 (8.10 %)
Last Updated: 29 Jan 2025 04:01 PM
BEARISH
Overview
Open (₹) 2,255.05
High (₹) 2,441.15
Low (₹) 2,227.75
Prev. Close (₹) 2,238.30
Volume 5,743
VWAP (₹) 2,176.26
ROCE (%) 30.97
Industry P/E 45.75
TTM P/E 50.57
P/B Ratio 10.64
Market Cap (₹) Cr.3,989.62
Dividend Yield (%)0.66
EPS (₹) 53.01
ROE23.39%
Sales Growth (%) 13.50
Profit Growth (%)29.60
Day Range
2,441.152,441.15
52 Week Range
1,363.902,976.70
Historical Returns
Returns (6M)
28.14 %
Returns (1Y)
49.95 %
Returns (3Y)
310.85 %
Returns (5Y)
747.91 %
Returns (6M)
28.14 %
Returns (1Y)
49.95 %
Returns (3Y)
310.85 %
Returns (5Y)
747.91 %
SWOT Analysis
- Growth in Net Profit Margin (QoQ)
- Increasing Revenue every Quarter for the past 4 Quarters
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Positive ROC (9) indicates upward momentum.
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
BEARISHRSI 50.93
MFI 60.27
ATR 117.82
Commodity Channel Index 38.03
ROC125 16.47
ROC21 4.56
Williams %R -32.11
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 2,302.49 | 2,366.67 | 2,467.94 | 2,201.22 | 2,137.04 | 2,035.77 | 1,971.59 |
| Week Ago | 2,174.01 | 2,199.78 | 2,222.16 | 2,151.63 | 2,125.86 | 2,103.48 | 2,077.71 |
| Month Ago | 2,146.61 | 2,183.33 | 2,202.56 | 2,127.38 | 2,090.66 | 2,071.43 | 2,034.71 |
EMA & SMA
2419.50
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 2134.40
9 Day 2129.29
10 Day 2117.86
12 Day 2154.04
14 Day 2169.09
20 Day 2153.63
26 Day 2173.58
50 Day 2168.86
100 Day 2312.43
200 Day 1997.73
Deals & Announcements
Bulk and Block Deals
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 26 Dec, 2024 | Nucleus Life Trust | Acquisition | ₹2,187.361111111111111111111111 | 1,800 | BSE |
| 24 Dec, 2024 | Nucleus Life Trust | Acquisition | ₹2,170.00 | 10 | BSE |
| 24 Dec, 2024 | Nucleus Life Trust | Acquisition | ₹2,174.220823798627002288329519 | 874 | BSE |
| 24 Dec, 2024 | Nucleus Life Trust | Acquisition | ₹2,196.00 | 10 | BSE |
| 24 Dec, 2024 | Nucleus Life Trust | Acquisition | ₹2,195.381212723658051689860835 | 2,012 | BSE |
| 20 Dec, 2024 | Nucleus Life Trust | Acquisition | ₹2,197.208835341365461847389558 | 249 | BSE |
| 20 Dec, 2024 | Nucleus Life Trust | Acquisition | ₹2,233.00 | 500 | BSE |
| 18 Dec, 2024 | Nucleus Life Trust | Acquisition | ₹2,254.051515151515151515151515 | 330 | BSE |
| 18 Dec, 2024 | Nucleus Life Trust | Acquisition | ₹2,270.05 | 200 | BSE |
| 16 Dec, 2024 | Nucleus Life Trust | Acquisition | ₹2,253.723611111111111111111111 | 720 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 30 Apr, 2024 | Rs.16.0000 per share(200%)Final Dividend | 28 Jun, 2024 | 28 Jun, 2024 |
| 28 Apr, 2023 | Rs.12.0000 per share(150%)Final Dividend | 21 Jul, 2023 | 21 Jul, 2023 |
| 29 Apr, 2022 | Rs.9.6000 per share(120%)Final Dividend | 14 Jul, 2022 | 15 Jul, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 28 Jan, 2025 | BSE India | Please find enclosed herewith copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter ended December 31, 2024. |
| 25 Jan, 2025 | NSE India | In terms of the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter ended December 31, 2024.Kindly take this information on record. |
| 24 Jan, 2025 | NSE India | RPG Life Sciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
| 24 Jan, 2025 | NSE India | RPG Life Sciences Limited has informed the Exchange regarding a press release dated January 24, 2025, titled ""Please find enclosed herewith a copy of press release with respect to Unaudited Financial Results of the Company for the quarter ended December 31, 2024"". |
| 24 Jan, 2025 | BSE India | Please find enclosed herewith a copy of press release with respect to Unaudited Financial Results of the Company for the quarter ended December 31, 2024. |
| 24 Jan, 2025 | NSE India | The Company has informed the Exchange regarding Board approval for revision in the Code of Conduct under SEBI (PIT) Regulations, 2015 |
| 24 Jan, 2025 | NSE India | Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, read with BSE Circular No. 20250102-4 and NSE Circular No. NSE/CML/2025/02 dated January 2, 2025, we are submitting herewith the Integrated Filing (Financial) for the quarter ended December 31, 2024. |
| 24 Jan, 2025 | BSE India | Pursuant to SEBI Circular dated December 31, 2024 read with BSE Circular and NSE Circular dated January 2, 2025, we are submitting herewith the Integrated Filing (Financial) for the quarter ended December 31, 2024. |
| 24 Jan, 2025 | BSE India | Unaudited Financial Results for the period ended December 31, 2024 are enclosed. |
| 24 Jan, 2025 | NSE India | In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Friday, January 24, 2025, inter-alia, considered and approved the 1. Unaudited Financial Results of the Company for the quarter ended December 31, 2024 and Intimation about change in Code/Policy. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 20 Jan, 2025 | 24 Jan, 2025 |
| Quarterly Results | -- | 02 Nov, 2024 | 07 Nov, 2024 |
| Quarterly Results | -- | 15 Jul, 2024 | 19 Jul, 2024 |
| Audited Results & Final Dividend | -- | 24 Apr, 2024 | 30 Apr, 2024 |
| Quarterly Results | -- | 30 Jan, 2024 | 01 Feb, 2024 |
| Quarterly Results | -- | 12 Oct, 2023 | 18 Oct, 2023 |
| Quarterly Results | -- | 24 Jul, 2023 | 28 Jul, 2023 |
| Audited Results & Final Dividend | -- | 24 Apr, 2023 | 28 Apr, 2023 |
| Quarterly Results | -- | 26 Jan, 2023 | 01 Feb, 2023 |
| Quarterly Results | -- | 11 Oct, 2022 | 17 Oct, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About RPG Life Sciences
RPG Life Sciences is a Public Limited Listed company incorporated on 29/03/2007 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24232MH2007PLC169354 and registration number is 169354. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 582.05 Cr. and Equity Capital is Rs. 13.23 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
R P Goenka Group
Founded
2007
Managing Director
Mr. Yugal Sikri
NSE Symbol
RPGLIFE
RPG Life Sciences Management
| Name | Designation |
|---|---|
| Mr. Harsh V Goenka | Chairman |
| Mr. Yugal Sikri | Managing Director |
| Mr. Rajat Bhargava | Non Executive Director |
| Mr. Sachin Nandgaonkar | Independent Director |
| Mr. Manoj K Maheshwari | Independent Director |
| Mr. Narendra Ambwani | Independent Director |
| Ms. Zahabiya Khorakiwala | Independent Director |
| Mr. Bhaskar Iyer | Independent Director |
| Dr. Lalit S Kanodia | Independent Director |
| Mr. Mahesh S Gupta | Independent Director |
| Mr. Hiten Kotak | Independent Director |
| Mr. Anil Matai | Independent Director |
| Ms. Radhika Gupta | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,735.35  ₹1,705.50(1.75%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,620.15 ₹5,410.20(3.88%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,423.95 ₹1,420.60(0.24%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,477.45 ₹2,456.70(0.84%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,181.20  ₹1,181.25(-0.00%) | ₹1,104.690 - ₹1,420.200 |
FAQs on RPG Life Sciences
What is the share price of RPG Life Sciences?
The share price of RPG Life Sciences on 29 Jan, 2025 is ₹ 2,419.50.
What is 52W high and 52W low share price of RPG Life Sciences?
The highest and lowest 52W share prices of RPG Life Sciences are ₹ 2976.700 and ₹ 1306.400
What is the market cap of RPG Life Sciences?
The market capitalization of RPG Life Sciences as of 29 Jan, 2025 is ₹ 3,989.62 Crores
What is the P/E ratio of RPG Life Sciences?
The current P/E ratio of RPG Life Sciences as of 29 Jan, 2025 is 45.75
What is the PB ratio of RPG Life Sciences?
The PB ratio of RPG Life Sciences as of 29 Jan, 2025 is 10.64
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)